2374 related articles for article (PubMed ID: 8242663)
1. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
Hoon DS; Hayashi Y; Morisaki T; Foshag LJ; Morton DL
Cancer Immunol Immunother; 1993 Nov; 37(6):378-84. PubMed ID: 8242663
[TBL] [Abstract][Full Text] [Related]
2. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
[TBL] [Abstract][Full Text] [Related]
7. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
Young MR; McCloskey G; Wright MA; Pak AS
Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
Mazzocchi A; Anichini A; Castelli C; Sensi M; Poli F; Russo C; Parmiani G
Cancer Immunol Immunother; 1990; 32(1):13-21. PubMed ID: 2149669
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
Matsuda M; Salazar F; Petersson M; Masucci G; Hansson J; Pisa P; Zhang QJ; Masucci MG; Kiessling R
J Exp Med; 1994 Dec; 180(6):2371-6. PubMed ID: 7964510
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.
Kirkin AF; thor Straten P; Zeuthen J
Cancer Immunol Immunother; 1996 May; 42(4):203-12. PubMed ID: 8665567
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 on cultured human melanoma cells: influence of cytokines.
Yoneda K; Mori S; Takemura M; Noma A; Yamamoto A
J Dermatol; 1993 Mar; 20(3):144-50. PubMed ID: 8097520
[TBL] [Abstract][Full Text] [Related]
14. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
15. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
16. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
18. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
Norose K; Yano A
Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
[TBL] [Abstract][Full Text] [Related]
19. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
20. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
Thornhill MH; Haskard DO
J Immunol; 1990 Aug; 145(3):865-72. PubMed ID: 1695647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
